Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP410590.RAZra-Xue3_fndmEy4ZtP_NMzCHNy5VArRsmP0XKex1dE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP410590.RAZra-Xue3_fndmEy4ZtP_NMzCHNy5VArRsmP0XKex1dE130_assertion type Assertion NP410590.RAZra-Xue3_fndmEy4ZtP_NMzCHNy5VArRsmP0XKex1dE130_head.
- NP410590.RAZra-Xue3_fndmEy4ZtP_NMzCHNy5VArRsmP0XKex1dE130_assertion description "[Recombinant interferon gamma has shown only limited success in the treatment of metastatic renal cell carcinoma (RCC), both as a single agent and in combination with recombinant interferon alfa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410590.RAZra-Xue3_fndmEy4ZtP_NMzCHNy5VArRsmP0XKex1dE130_provenance.
- NP410590.RAZra-Xue3_fndmEy4ZtP_NMzCHNy5VArRsmP0XKex1dE130_assertion evidence source_evidence_literature NP410590.RAZra-Xue3_fndmEy4ZtP_NMzCHNy5VArRsmP0XKex1dE130_provenance.
- NP410590.RAZra-Xue3_fndmEy4ZtP_NMzCHNy5VArRsmP0XKex1dE130_assertion SIO_000772 1341990 NP410590.RAZra-Xue3_fndmEy4ZtP_NMzCHNy5VArRsmP0XKex1dE130_provenance.
- NP410590.RAZra-Xue3_fndmEy4ZtP_NMzCHNy5VArRsmP0XKex1dE130_assertion wasDerivedFrom befree-2016 NP410590.RAZra-Xue3_fndmEy4ZtP_NMzCHNy5VArRsmP0XKex1dE130_provenance.
- NP410590.RAZra-Xue3_fndmEy4ZtP_NMzCHNy5VArRsmP0XKex1dE130_assertion wasGeneratedBy ECO_0000203 NP410590.RAZra-Xue3_fndmEy4ZtP_NMzCHNy5VArRsmP0XKex1dE130_provenance.